A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.

NCT02240017 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Advanced Urothelial Cancer
Metastatic Urothelial Cancer

Interventions

DRUG: Carboplatin
DRUG: Fractionated Cisplatin
DRUG: Gemcitabine

Sponsor

Institut Claudius Regaud